No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database.
about
Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsNo Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data.Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.Neuropsychiatric Effects of HIV Antiviral Medications.The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine care.A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications.Switching antiretroviral regimes for the treatment of HIV: safety implications.Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.Cost considerations in the current antiretroviral era.Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race.Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population.Characterizing drug-related adverse events by joint analysis of biomedical and genomic data: A case study of drug-induced pulmonary fibrosis.British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q28081266-ED805F3D-212A-44BD-8DCB-E11C947A8893Q31040458-820F9C3B-662A-415E-B6BF-1E6A2EB02B42Q31114073-BD04057D-CE23-4BA4-A920-FF3C7288B43AQ34536677-78C57190-9718-443B-8255-C6C5C361234FQ34537705-D513E3D4-3820-4328-961A-87FF2412CA5DQ38657643-6DD04E50-3A58-4CE4-9D2A-98420CFC4C96Q38743628-72ED7C67-3AE3-4CE6-807D-3FF4DBBDF04EQ38879406-B56A4CED-E9E2-4259-A463-FD8D6A082F21Q38987587-D69A88B7-10E4-4947-AE35-3FA46E431E47Q39194185-93D1581B-F44A-4B32-A447-FF80748FD535Q39503882-9BC1AD6F-68F1-4E06-9596-E99591ADD898Q41995975-73FB08D5-08E0-4822-925A-A228BEB57578Q50051675-35D0E61A-22FF-4353-8513-72C997453FFBQ52655906-46A8346C-79D6-4841-BEB3-AEA2365693D9Q54211761-FB160D6A-DC05-4E2B-BF0B-4DB70145A456Q55009284-5DB9B64B-BEEB-4EAE-A686-7ECDC1DC28C0Q57180790-7F4E2747-E25B-47DD-926A-EE0124FCC22A
P2860
No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
No evident association between ...... ysis using the FAERS database.
@en
type
label
No evident association between ...... ysis using the FAERS database.
@en
prefLabel
No evident association between ...... ysis using the FAERS database.
@en
P2093
P2860
P921
P356
P1476
No evident association between ...... ysis using the FAERS database.
@en
P2093
Amit M Soitkar
Andrew A Napoli
Daniel W Seekins
Hugh H Tilson
Jennifer J Wood
John J Coumbis
P2860
P356
10.7448/IAS.17.1.19214
P577
2014-09-04T00:00:00Z